Concourse Financial Group Securities’s ETF Series Solutions Trust Range Cancer Therapeutics ETF CNCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Hold |
0
| – | – | – | 1567 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 3419 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 3413 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 3460 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 3470 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 3416 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 3410 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 3389 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 3335 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 3282 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 3072 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 3139 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 3093 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 3251 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 3219 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 3138 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 3083 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 3027 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 2881 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 2786 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 2838 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 2786 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 2486 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 2860 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 2835 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 2709 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 2265 |
|